CureVac Files November 2025 6-K Report
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | Nov 26, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
CureVac filed its monthly 6-K report on Nov 26, 2025, standard procedure for foreign issuers.
AI Summary
CureVac N.V. filed a Form 6-K on November 26, 2025, reporting for the month of November 2025. The filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. CureVac N.V. is incorporated in Germany and its principal executive office is located in Tübingen.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding CureVac's status as a foreign private issuer. It confirms ongoing compliance with SEC reporting requirements.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain new material financial information or strategic changes.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- 20251126 (date) — Filing Date
- November 2025 (date) — Reporting Period
- Tübingen, Germany (location) — Principal Executive Office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was this specific Form 6-K filed?
This Form 6-K was filed on November 26, 2025.
What period does this Form 6-K cover?
This Form 6-K reports for the month of November 2025.
Where is CureVac N.V.'s principal executive office located?
CureVac N.V.'s principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Is CureVac N.V. required to file annual reports under Form 20-F?
Yes, the filing indicates that CureVac N.V. files or will file annual reports under Form 20-F.
Filing Stats: 287 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-11-26 10:10:44
Filing Documents
- tm2532279d1_6k.htm (6-K) — 12KB
- tm2532279d1_ex99-1.htm (EX-99.1) — 33KB
- tm2532279d1_ex99-1img001.jpg (GRAPHIC) — 11KB
- 0001104659-25-116274.txt ( ) — 61KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CureVac N.V. (Registrant) Date: November 26, 2025 By: /s/ Alexander Zehnder Chief Executive Officer EXHIBIT INDEX EXHIBIT NO. DESCRIPTION 99.1 CureVac N.V. Press Release dated November 25, 2025